News for Healthier Living

KCC2 Modulation Improves Neuromuscular Function in Dystrophic Mice

A research team has found that pharmacologically enhancing neuronal chloride regulation improves locomotor performance and reshapes neural and metabolic signatures across the neuromuscular axis in a mouse model of Duchenne muscular dystrophy (DMD). Seven days of treatment with CLP290, a prodrug designed to enhance the activity of the potassium-chloride cotransporter KCC2, increased KCC2 expression in spinal motor neurons, strengthened inhibitory signaling, reduced markers associated with neuronal hyperexcitability, and improved gait stability. The findings suggest that targeting neural homeostasis could complement muscle-directed treatments and potentially help preserve mobility during the early stages of DMD.

October 12, 2026


October 12 2026

October 11 2026

October 10 2026

October 9 2026

October 8 2026

October 7 2026

October 6 2026

October 5 2026

October 2 2026

October 1 2026

September 30 2026

September 29 2026

September 28 2026